Larry Luchsinger, PhD

Senior Vice President & Chief Scientific Officer

Larry Luchsinger, PhD, is Senior Vice President and Chief Scientific Officer for New York Blood Center Enterprises (NYBCe). He also serves as Director of Research Operations at LFKRI, Head of the Laboratory of Stem Cell Regenerative Research, and Director of the NYBC iPSC Program.

Larry Luchsinger, PhD, NYBCe

He oversees NYBCe’s Lindsley F. Kimball Research Institute (LFKRI) and the strategy and implementation of NYBCe’s research and development activities to foster a culture of collaboration and excellence among the organization’s diverse and talented scientists.

He spearheads LFKRI’s recharge initiative to expand research laboratories, support new investigator-initiated grant opportunities, elevate research capabilities, and develop external scientific collaborations. He is also leading the rebranding of LFKRI into core pillars of research and ‘Centers of Excellence,’ highlighting the overlap between laboratories or ‘Research Hubs,’ enabling visibility to external partners interested in the expertise and capabilities of LFKRI. 

Dr. Luchsinger’s research focuses on exploring the basic biology of hematopoietic stem cells (HSC) towards improving transplant outcomes in patients and LFKRI’s research efforts to create an immunotolerant Induced Pluripotent Stem Cell (iPSC) Bank. He was awarded a $2.5 million grant from the National Heart, Lung, and Blood Institute to complete a five-year research project entitled Hormetric ER Stress Regulation of Hematopoietic Stem Cell Function. He also received the American Association of Blood Bank’s National Blood Foundation (NBF) Scientific Research Grant.  

He earned his B.S. in Chemistry from Marquette University. He earned his M.A. in Chemistry from Boston University and his PhD in Biochemistry from the Boston University School of Medicine. He completed his postdoctoral studies at Columbia University Medical Center. 

Co-author of over 30 peer-reviewed publications, he is an associate editor of the Blood Cells, Molecules, and Diseases (BCMD) Journal, an ad hoc reviewer of NIH Basic Biology of Blood, Heart, Vasculature (BBHV) and Fellowships in Vascular and Hematological Systems (F grants), and a sub-awardee participant with Columbia and Mt. Sinai.